Successful Treatment of Generalized Pustular Psoriasis of Pregnancy with Oral Cyclosporine
Main Article Content
Keywords
Pregnancy, Pustular Psoriasis, Cyclosporine
Abstract
Generalized pustular psoriasis of pregnancy (GPPP) is a rare dermatosis that usually occurs during the third trimester of pregnancy. The diagnosis is primarily clinical, confirmed by laboratory investigations and histopathological typical findings. Here we report, a 26-year-old, gravida one woman, in 37 weeks of pregnancy, presenting with extensive erythematous, pruritic plaques with peripheral scaling and pustules. Patient was induced at 37+4 weeks and delivered a healthy 2900g male infant. GPPP was eventually controlled with oral cyclosporine.
References
2. Shah A, Makhecha M. Pustular Psoriasis of Pregnancy with Acrodermatitis Continua of Hallopeau. Indian J Dermatol. 2016;61(1):123.
3. Hazarika D. Generalized pustular psoriasis of pregnancy successfully treated with cyclosporine. Indian J Dermatol Venereol Leprol. 2009;75(6):638.
4. Oumeish OY, Farraj SE, Bataineh AS. Some aspects of impetigo herpetiformis. Arch Dermatol 1982;118:103-5.
5. Nasser N, Sasseville D. Dermatologic diseases of pregnancy. Dermatologie - Conferences Scientifiques. 2006;5:1–6.
6. Shaw CJ, Wu P, Sriemevan A. First trimester impetigo herpetiformis in multiparous female successfully treated with oral cyclosporine. BMJ Case Rep. 2011;12:11-20.
7. Champion RH, Burton JL, Burns DA. Rook’s Textbook of Dermatology. Sixth edition Oxford: Blackwell Scientific Publications. 1998;16:39-40.
8. Keerthi S, Rangaraj M, Karthikeyan K. Telmisartan aggravates pustular psoriasis. J Pharmacol Pharmacother. 2015;6(2):107-9.
9.Patsatsi A, Theodoridis TD, Vavilis D, Tzevelekis V, Kyriakou A, Kalabalikis D, et al. Cyclosporine in the management of impetigo herpetiformis: a case report and review of the literature. Case Rep Dermatol. 2013;5(1):99-104.
10. Kondo RN, Araújo FM, Pereira AM, Lopes VC, Martins LM. Pustular psoriasis of pregnancy (impetigo herpetiformis)-case report. An Bras Dermatol. 2013;88(6):186-9.
11. Azulay-Abulafia L, Brotas A, Braga A, Volta AC, Gripp AC. Psoríase pustulosa da gestação (impetigo herpetiforme): relato de dois casos e revisão na literatura. Rev Bras Ginecol Obstet. 2004;26:153–159.
12. Vun YY, Jones B, Al-Mudhaffer M, Egan C. Generalized pustular psoriasis of pregnancy treated with narrowband UVB and topical steroids. J Am Acad Dermatol. 2006;54(2):28–30.
13. Bin Yap FB. Impetigo herpetiformis: A rare dermatosis of pregnancy. South Med J. 2009;102:1186–7.
14. Roth MM. Pregnancy dermatoses: diagnosis, management, and controversies. Am J Clin Dermatol. 2001;12:25–41
15. Brightman L, Stefanato CM, Bhawan J, Phillips TJ. Third-trimester impetigo herpetiformis treated with cyclosporine. J Am Acad Dermatol. 2007;56(2): 62–4
16. Martins GA, Arruda L. Systemic treatment of psoriasis - Part I: methotrexate and acitretin. An Bras Dermatol. 2004;79:263–278.
17. Okuno H, Ogura K, Okuyama R, Itoi E. Two cases of acrodermatitis continua of Hallopeau associated with generalized arthritis. Acta Dermatovenerol Croat. 2013;21:265–7
18. Imai N, Watanabe R, Fujiwara H, Ito M, Nakamura A. Successful treatment of impetigo herpetiformis with oral cyclosporine during pregnancy. Arch Dermatol. 2002;138(1):128–9.
19. Arslanpence I, Dede FS, Gokcu M, Gelisen O. Impetigo herpetiformis unresponsive to therapy in a pregnant adolescent. J Pediatr Adolesc Gynecol. 2003;16(3):129–132.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation.
Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.
Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.